探索在中心每周三次夜间血液透析患者中普遍存在的血管接入生存率
Katherine L Hull1,2, Ann Bugeja3,4, Matthew P M Graham-Brown5,6,7,8
1Department of Cardiovascular Sciences, University of Leicester, Leicester, UK. kh326@leicester.ac.uk.
Journal of nephrology
|September 26, 2025
概括
与传统血液透析相比,中心夜间血液透析 (INHD) 没有增加血管接入并发症的风险. 血管接入类型和抗凝剂显著影响存活率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 血管外科 血管外科
- 内部医学 内部医学
背景情况:
- 血管接入并发症对于接受血液透析的患者来说是一个重大问题.
- 在中心夜间血液透析 (INHD) 提供了传统白天血液透析的替代方案.
- 将INHD和常规血液透析之间的血管接入并发症率进行比较对于患者护理至关重要.
研究的目的:
- 为了评估接受INHD和常规血液透析的患者血管接入并发症的风险.
- 确定影响血液透析患者血管接入生存的因素.
主要方法:
- 作为自身对照的患者进行了回顾性队列研究.
- 2009年至2021年间从三个中心收集的数据.
- 主要结局:综合住院,干预,模式变化或与血管接入有关的死亡,使用时间到事件率进行分析.
主要成果:
- 在INHD和常规血液透析之间的初级复合结果中没有显著差异 (24.1%与25.5%,P=0.875).
- 12个月的血管接入生存概率是可比的 (INHD的73.4%与传统的70.6%相比).
- 动脉静脉移植和定期使用维生素K对抗剂与减少血管接入的存活率有关.
结论:
- 与白天血液透析相比,INHD似乎不会增加血管接入事件的风险.
- 血管接入类型和定期的抗凝血是影响血管接入生存的关键因素.
相关概念视频
Hemodialysis I: Introduction
1.1K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
Hemodialysis II: Procedure and Complications
547
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
547
Hemodialysis III: Nursing Management
675
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
675
Continuous Renal Replacement Therapy
713
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
713
Peritoneal Dialysis III: Nursing Management
580
Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
580
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
453
Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
453


